Amanote Research

Amanote Research

    RegisterSign In

The K+channels KCa3.1 and Kv1.3 as Novel Targets for Asthma Therapy

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.2009.00362.x
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

August 1, 2009

Authors
Peter BraddingHeike Wulff
Publisher

Wiley


Related search

The Voltage-Dependent K+ Channels Kv1.3 and Kv1.5 in Human Cancer

Frontiers in Physiology
Physiology
2013English

Novel Targets for Stroke Therapy: Special Focus on TRPC Channels and TRPC6

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2020English

Small K Channels: Big Targets for Treating Alcoholism?

Biological Psychiatry
Biological Psychiatry
2011English

Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

K2P Channels: Emerging Targets for Novel Analgesic Drugs

British Journal of Pharmacology
Pharmacology
2018English

Novel Endocrine Targets for GBM Therapy

2016English

TRPA1 Channels as Novel Molecular Targets for Anti-Inflammatory Therapies in CF Lung

Postdoc Journal
2016English

Novel Biomarkers for Asthma Stratification and Personalized Therapy

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2014English

Ion Channels as Insecticide Targets

Journal of Neurogenetics
Molecular NeuroscienceGeneticsCellular
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy